NBRV - Nabriva Therapeutics plc (NBRV) CEO Theodore Schroeder on Q3 2021 Results - Earnings Call Transcript

Nabriva Therapeutics plc (NBRV) Q3 2021 Results Conference Call November 09, 2021 04:30 PM ET Company Participants Theodore Schroeder - Chief Executive Officer Dan Dolan - Chief Financial Officer Steve Gelone - President and Chief Operating Officer Conference Call Participants Carl Byrnes - Northland Securities Suji Jeong - Jefferies Presentation Operator Good day and thank you for standing by. Welcome to the Nabriva Therapeutics Third Quarter 2021 Business Update and Financial Results Call. At this time, all participants are in a listen-only mode. After the speaker presentation there will be a question-and-answer session. [Operator Instructions] I would now like to hand the conference over to your speaker today, Mr. Dan Dolan, Nabriva’s, Chief Financial Officer. Dan Dolan Thank you, and good afternoon, everyone. Welcome to the Nabriva’s conference call and webcast where we will discuss the third quarter 2021 earnings and also provide a business update. The Slides for today's

For further details see:

Nabriva Therapeutics plc (NBRV) CEO Theodore Schroeder on Q3 2021 Results - Earnings Call Transcript